24/01/2013 - Press release
Researchers participating in the REGICOR Study (Girona Heart Registry), with the participation of IMIM (Hospital del Mar Medical Research Institute) from Barcelona, the Josep Trueta Hospital, the Blanes Hospital and IDIAP Jordi Gol from Girona (Primary Healthcare Research Institute) have carried out a study to assess the impact of the partial smoke-free legislation passed in 2006 on the incidence of acute myocardial infarction in the province of Girona and observed it has dropped 11%. This decrease has been noticed especially among women, population aged between 65 and 74, and among non-smokers. Researchers analysed data from 3,703 infarctions occurred in Girona between the years 2002 and 2008 and studied whether the number of infarctions had dropped during the period 2006-2008 (after the implementation of the law) compared to the data from the period running from 2002 to 2004 (before the law was in place).
20/12/2012 - Institutional news
On Friday the 14th of December, the Bioanalysis and Analytical Services Research Group from IMIM (Hospital del Mar Medical Research Institute) was visited by a delegation from the China Anti-Doping Agency (CHINADA). This visit is framed within the longstanding collaboration between the Anti-Doping Control Laboratory and IMIM and the Beijing Anti-Doping Laboratory and the China Anti-Doping Agency for research projects on doping control in sports.
Més informació "A delegation from the China Anti-Doping Agency visits IMIM"
11/12/2012 - Press release
An international project with the participation of researchers from IMIM has, for the first time ever, deciphered the mechanism by which a substance called anophelin binds to an enzyme (thrombin) involved in the process of blood coagulation. This discovery opens the door to, on the one hand, designing a new generation of anticoagulant drugs with a totally different functioning to current ones and, on the other hand, fighting against the spreading of malaria by designing inhibitors for this substance.
Més informació "New anticoagulant discovered based on the same used by malaria vectors to feed on"
04/12/2012 - Press release
Bioinformaticians at IMIM and UPF have used molecular simulation techniques to explain a specific step in the maturation of the HIV virions, essential in understanding how the virus replicates. These results, which have been published in the latest edition of PNAS, could be crucial to the design of future antiretrovirals.The work has been carried out using GPUGRID.net, a voluntary distributed computing platform leveraging GPU accelerators to deliver “virtual supercomputing” performance.
Més informació "Crucial step in AIDS virus maturation simulated for first time"
27/11/2012 - General information
Two studies led by researchers from the neuroimaging research group at IMIM led by Òscar Vilarroya, and which also involved researchers from UAB and the Hospital de la Vall d’Hebron, have been cited in the “Consensus Report of the APA Work Group” as international reference works in the area of attention deficit and hyperactivity disorder (ADHD), conferring upon these researchers the status of world leaders in this field.
Més informació "IMIM researchers world leaders in neuroimaging and ADHD research"
20/11/2012 - Press release
Exposure to dioxins during pregnancy is associated with endocrine-disrupting effects in male infants. Genitalia distances that normally are longer in males than females, were reduced among male newborns whose mothers had higher exposure to dioxins. This is revealed in a study of 700 pregnant women and newborns from Greece and Spain.
23/10/2012 - Press release
Intake of foods high in acrylamide during pregnancy is associated with lower birth weight and smaller head circumference. This was revealed in an international study of the diet of 1,100 pregnant women and newborns from Denmark, England, Greece, Norway and Spain in which IMIM has participated.
9/10/2012 - Press release
Patients with breast cancer that undergo a selective sentinel lymph node biopsy have a better quality of life 12 months after surgery than those submitted to lymph node dissection. "Until now, there was a slight controversy as to the benefits in terms of the quality of life of patients undergoing a sentinel lymph node biopsy compared to a lymph node dissection.” says Roser Belmonte, a doctor at the Department of Physical Medicine and Rehabilitation at Hospital del Mar-Esperança and a researcher at IMIM.
04/10/2012 - Press release
Researchers from IMIM, have succeeded in determining the function of a new variant of enzyme IKKalpha (IKKα) to activate some of the genes taking part in the tumor progressions of colorectal cancer. In the future, this fact will make it possible to design new drugs that inhibit this enzyme specifically and are less toxic for the remaining body cells, hence improving the treatment for this disease.
Més informació "New function of a protein involved in colon cancer is identified"
12/09/2012 - General information
The project- based on a collaboration agreement between the Barcelona Science Park (PCB) and the companies SOM Biotech and Metasbio– will enable the discovery of new therapeutic applications of previously existing drugs (repurposing), especially in areas of great medical need and market potential, such as the central nervous system, oncology and orphan diseases.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact